Niacin attenuates lung inflammation and improves survival during sepsis by downregulating the nuclear factor-κB pathway

Critical Care Medicine

Volumn 39, Issue 2, 2011, Pages 328-334

  Kwon, Woon Yong ^a   Suh, Gil Joon ^a   Kim, Kyung Su ^a   Kwak, Young Ho ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

cytokines; endotoxemia; lung in flammation; NF B; niacin; survival

Indexed keywords

GLUTATHIONE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MALONALDEHYDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; NICOTINIC ACID; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MEGADOSE; HISTOPATHOLOGY; LOW DRUG DOSE; MALE; NASOGASTRIC TUBE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RAT; SEPSIS; SURVIVAL; TISSUE LEVEL;

EID: 79251539159     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181feeae4     Document Type: Article

References (34)

1. Cohen J: The immunopathogenesis of sepsis. Nature 2002; 19:885-891
2. Bhatia M, Moochhala S: Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol 2004; 202:145-156
3. Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J Med 2000; 342: 1334-1349
4. Fan J, Ye RD, Malik AB: Transcriptional mechanisms of acute lung injury. Am J Physiol Lung Cell Mol Physiol 2001; 281: L1037-L1050
5. Schwartz MD, Moore EE, Moore FA, et al: Nuclear factor-kappa B is activated in alveolar macrophages from patients with acute respiratory distress syndrome. Crit Care Med 1996; 24:1285-1292
6. Zingarelli B: Nuclear factor-kappaB. Crit Care Med 2005; 33:S414-S416
7. Bhoj VG, Chen ZJ: Ubiquitylation in innate and adaptive immunity. Nature 2009; 458: 430-437
8. Zhang K, Kaufman RJ: From endoplasmic- reticulum stress to the inflammatory response. Nature 2008; 454:455-462
9. Chima RS, Hake PW, Piraino G, et al: Ciglitazone ameliorates lung inflammation by modulating the inhibitor kappaB protein kinase/nuclear factor-kappaB pathway after hemorrhagic shock. Crit Care Med 2008; 36: 2849-2857
10. Meyers CD, Kamanna VS, Kashyap ML: Niacin therapy in atherosclerosis. Curr Opin Lipidol 2004; 15:659-665
11. Green PS, Vaisar T, Pennathur S, et al: Combined statin and niacin therapy remodels the high-density lipoprotein proteome. Circulation 2008; 118:1259-1267
12. van der Hoorn JW, de Haan W, Berbée JF, et al: Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden CETP mice. Arterioscler Thromb Vasc Biol 2008; 28:2016-2022
13. Yan Q, Briehl M, Crowley CL, et al: The NAD-precursors, nicotinic acid and nicotinamide upregulate glyceraldehyde-3-phosphate dehydrogenase and glucose-6-phosphate dehydrogenase mRNA in Jurkat cells. Biochem Biophys Res Commun 1999; 255: 133-136
14. Ganji SH, Qin S, Zhang L, et al: Niacin inhibits vascular oxidative stress, redoxsensitive genes, and monocyte adhesion to human aortic endothelial cells. Atherosclerosis 2009; 202:68-75
15. Gurujeyalakshmi G, Wang Y, Giri SN: Taurine and niacin block lung injury and fibrosis by down-regulating bleomycin-induced activation of transcription nuclear factor-kappaB in mice. J Pharmacol Exp Ther 2000; 293: 82-90
16. Piguet PF, Collart MA, Grau GE, et al: Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J Exp Med 1989; 170:655-663
17. Phan SH, Kunkel SL: Lung cytokine production in bleomycin-induced pulmonary fibrosis. Exp Lung Res 1992; 18:29-43
18. Zou L, Yang S, Champattanachai V, et al: Glucosamine improves cardiac function following trauma-hemorrhage by increased protein O-GlcNAcylation and attenuation of NF-{kappa}B signaling. Am J Physiol Heart Circ Physiol 2009; 296:H515-H523
19. Martins JO, Zanoni FL, Martins DO, et al: Insulin regulates cytokines and intercellular adhesion molecule-1 gene expression through nuclear factor-kappaB activation in LPS-induced acute lung injury in rats. Shock 2009; 31:404-409
20. Kwon WY, Suh GJ, Kim KS, et al: Glutamine attenuates acute lung injury by inhibition of high mobility group box protein-1 expression during sepsis. Br J Nutr 2010; 103:890-898
21. Cao L, Wang J, Tseu I, et al: Maternal exposure to endotoxin delays alveolarization during postnatal rat lung development. Am J Physiol Lung Cell Mol Physiol 2009; 296: L726-L737
22. Edelman DA, Jiang Y, Tyburski JG, et al: Cytokine production in lipopolysaccharideexposed rat lung pericytes. J Trauma 2007; 62:89-93 (Pubitemid 46102837)
23. Lee J, Kwon W, Jo Y, et al: Protective effects of ethyl pyruvate treatment on paraquatintoxicated rats. Hum Exp Toxicol 2008; 27: 49-54
24. Ohkawa H, Ohishi N, Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-358
25. Kiyonari Y, Nishina K, Mikawa K, et al: Lidocaine attenuates acute lung injury induced by a combination of phospholipase a2 and trypsin. Crit Care Med 2000; 28:484-489
26. Festing MF, Altman DG: Guidelines for the design and statistical analysis of experiments using laboratory animals. ILAR J 2002; 43: 244-258
27. Pantano C, Reynaert NL, van der Vliet A, et al: Redox-sensitive kinases of the nuclear factor- kappaB signaling pathway. Antioxid Redox Signal 2006; 8:1791-1806
28. Gloire G, Piette J: Redox regulation of nuclear post-translational modifications during NF-kappaB activation. Antioxid Redox Signal 2009; 11:2209-2222
29. Yao H, Yang SR, Kode A, et al: Redox regulation of lung inflammation: role of NADPH oxidase and NF-kappaB signalling. Biochem Soc Trans 2007; 35:1151-1155
30. Lauring B, Rosko K, Luo WL, et al: A comparison of the pharmacokinetics of two different formulations of extended-release niacin. Curr Med Res Opin 2009; 25:15-22
31. Lundholm L, Jacobsson L, Brattsand R, et al: Influence of nicotinic acid, niceritrol and beta- pyridylcarbinol on experimental hyperlipidemia and atherosclerosis in mini-pigs. Atherosclerosis 1978; 29:217-239
32. Guyton JR, Bays HE: Safety considerations with niacin therapy. Am J Cardiol 2007; 99: 22C-31C
33. Maio AD, Torres MB, Reeves RH: Genetic determinants influencing the response to injury, inflammation, and sepsis. Shock 2005; 23:11-17
34. Singleton KD, Serkova N, Beckey VE, et al: Glutamine attenuates lung injury and improves survival after sepsis: role of enhanced heat shock protein expression. Crit Care Med 2005; 33:1206-1213 (Pubitemid 40827366)